Dr. Laura Rosella
Scientific, Research and Ethics Program
"Being at PHO allows me to be at the interface of world-leading research that is directly used in public health policy and practice. Seeing the results of my research in action is the ultimate motivation; more importantly, I get a better appreciation of what the research needs are from the people that are using it so I can design my work accordingly."
Areas of Expertise
- epidemiological methods
- applied biostatistics
- population-based risk tools to support public health planning
- diabetes and obesity
- public health policy
- premature mortality
- socioeconomic gradients in health
Member, Banting and Best Diabetes Centre, Faculty of Medicine, University of Toronto
Academic Degrees and Accreditations
- Doctor of Philosophy (Epidemiology), Dalla Lana School of Public Health, University of Toronto
- Master of Health Sciences (Epidemiology and Community Health), Dalla Lana School of Public Health, University of Toronto
PHO Research Interests
- Support and evaluate public health activities across various content areas, including chronic and infectious disease.
- Studying the social and health determinants of premature mortality.
- Studying population-based approaches to reducing diabetes and obesity.
- Inform population intervention strategies using Population Risk Tools (PoRTs).
- Provide ongoing methodological and analytical support to PHO scientists for Institute for Clinical Evaluative Sciences’ (ICES) related projects.
PHO Research Activities
- Population health analytics in action: Improving impact, sustainability & equity of the health care system.
- Quantifying future risk and burden of type 2 diabetes in Canada.
- Investigating biomarkers for type 2 diabetes and pre-diabetes.
- Investigating the characteristics and upstream determinants of high-cost users of Ontario’s health care system.
- Examining partnerships to guide the adaption, implementation, and evaluation of DPoRT within local (e.g., public health units), provincial (e.g., Ministry of Health and Long-Term Care), and Canadian context.
- The ORAD (Oral Health and Diabetes) Study.
- Neighbourhood walkability and chronic disease risk in Canada.
- Hepatitis B in migrants and the general population in Ontario in 2010-12.
- Khan AM, Urquia M, Kornas K, Henry D, Cheng SY, Bornbaum C, Rosella LC. Socioeconomic gradients in all-cause, premature and avoidable mortality using among immigrants and long-term residents using linked deaths records in Ontario, Canada. J Epidemiol Community Health. 2017;71:625-32.
- Rosella LC, Calzavara A, Frank J, Fitzpatrick T, Donnelly P. Henry D. Narrowing mortality gap between men and women over two decades: a registry-based study in Ontario, Canada. BMJ Open. 2016;6(11):e012564.
- Rosella LC, Bowman C, Pach B, Morgan S, Fitzpatrick T, Goel V. The development and validation of a meta-tool for quality appraisal of public health evidence: Meta Quality Appraisal Tool (MetaQAT). Public Health. 2016;136:57-65.
- Rosella LC, Lebenbaum M, Fitzpatrick T, O’Riley D, Wang J, Booth GL, Stukel TA, Wodchis W. Impact of diabetes on healthcare costs in a population-based cohort: A cost analysis. Diabet Med. 2016;33(3):395-403.
- Rosella LC, Lebenbaum M, Fitzpatrick T, Zuk A, Booth GL. The prevalence of prediabetes and undiagnosed diabetes in Canada (2007-2011): according to fasting plasma glucose and HbA1c screening criteria. Diabetes Care. 2015;38(7):1299-305.